Aixial

Aixial

Since 1999, Aixial Group has been a leader in oncology-focused clinical research, offering customised solutions for the biopharma and biotech industries. Specialising in complex trial designs such as dose escalation, adaptive, and umbrella trials, we support both early and late-phase oncology studies. With 100% oncology experience, we've conducted over 300 studies across 7,400 sites globally, involving 71,000 patients. Our expert team prioritises high-quality service, proactive partnership, and timely delivery of innovative oncology therapies worldwide.

Breast Cancer, Central Nervous System Tumors, Gynecologic Cancer, Head and Neck Cancer, Lung Cancer, Melanoma/Skin Cancers, Clinical Trials

Yes